Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation

Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation: a Randomized Controlled Trial

Introduction: Renal transplantation represents the therapeutic mode with more durable treatment, greater cost-effectiveness, survival benefits and quality of life of the patients, however, with high cardiovascular mortality.

Objectives: To evaluate the acute and chronic effects on heart rate variability and the impact of chronic kidney disease on cardiorespiratory fitness in renal transplant recipients following a full-body Vibration training program.

Methods: It will be a blinded randomized clinical trial (patient, evaluator and statistician), controlled and endowed with secrecy of allocation, to be performed in the Cardiopulmonary Physiotherapy Laboratory of the Physiotherapy Department of the Federal University of Pernambuco. Renal transplant recipients will be recruited at the Nephrology outpatient clinic of the Hospital das Clínicas de Pernambuco, according to the following inclusion criteria: age between 18 and 59 years, who underwent transplantation at least one year before and present a stable transplant function through the level Of creatinine

It will be a blinded randomized clinical trial (patient, evaluator and statistician), controlled and endowed with secrecy of allocation, to be performed in the Cardiopulmonary Physiotherapy Laboratory of the Physiotherapy Department of the Federal University of Pernambuco. Renal transplant recipients will be recruited at the Nephrology outpatient clinic of the Hospital das Clínicas de Pernambuco, according to the inclusion criteria

Inclusion Criteria:

• Age between 18 and 59 years
• who underwent transplantation at least one year before
• present a stable transplantation function through the creatinine level <1.8 mg / dL
• No drug use with ability to modify the autonomic nervous system, such as sympatholytic drugs

Exclusion Criteria:

• unstable hypertension;
• Amyloidosis;
• Congestive heart failure, recent myocardial infarction, unstable angina;
• Musculoskeletal abnormality that impairs the performance of the exercises;
• Have a metal implant or cardiac pacemaker.